Reviews - 3q7b mentioned but not cited (1)
- Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses. Hastie KM, Bale S, Kimberlin CR, Saphire EO. Curr Opin Virol 2 151-156 (2012)
Articles - 3q7b mentioned but not cited (2)
Reviews citing this publication (67)
- Nucleoproteins and nucleocapsids of negative-strand RNA viruses. Ruigrok RW, Crépin T, Kolakofsky D. Curr. Opin. Microbiol. 14 504-510 (2011)
- Conventional and unconventional mechanisms for capping viral mRNA. Decroly E, Ferron F, Lescar J, Canard B. Nat. Rev. Microbiol. 10 51-65 (2011)
- Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5. Reikine S, Nguyen JB, Modis Y. Front Immunol 5 342 (2014)
- Viral evasion of intracellular DNA and RNA sensing. Chan YK, Gack MU. Nat. Rev. Microbiol. 14 360-373 (2016)
- Recent advances in understanding viral evasion of type I interferon. Taylor KE, Mossman KL. Immunology 138 190-197 (2013)
- Ribonuclease III mechanisms of double-stranded RNA cleavage. Nicholson AW. Wiley Interdiscip Rev RNA 5 31-48 (2014)
- Current progress in antiviral strategies. Lou Z, Sun Y, Rao Z. Trends Pharmacol. Sci. 35 86-102 (2014)
- Emerging virus diseases: can we ever expect the unexpected? Howard CR, Fletcher NF. Emerg Microbes Infect 1 e46 (2012)
- The polymerase of negative-stranded RNA viruses. Morin B, Kranzusch PJ, Rahmeh AA, Whelan SP. Curr Opin Virol 3 103-110 (2013)
- Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. Zinzula L, Tramontano E. Antiviral Res. 100 615-635 (2013)
- Structural perspective on the formation of ribonucleoprotein complex in negative-sense single-stranded RNA viruses. Zhou H, Sun Y, Guo Y, Lou Z. Trends Microbiol. 21 475-484 (2013)
- Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. McLay L, Liang Y, Ly H. J. Gen. Virol. 95 1-15 (2014)
- Multifunctional nature of the arenavirus RING finger protein Z. Fehling SK, Lennartz F, Strecker T. Viruses 4 2973-3011 (2012)
- Advanced vaccine candidates for Lassa fever. Lukashevich IS. Viruses 4 2514-2557 (2012)
- Global virus outbreaks: Interferons as 1st responders. Wang BX, Fish EN. Semin Immunol 43 101300 (2019)
- Interplay between viruses and host mRNA degradation. Narayanan K, Makino S. Biochim. Biophys. Acta 1829 732-741 (2013)
- Arenavirus variations due to host-specific adaptation. Zapata JC, Salvato MS. Viruses 5 241-278 (2013)
- Immune responses and Lassa virus infection. Russier M, Pannetier D, Baize S. Viruses 4 2766-2785 (2012)
- Segmented negative strand RNA virus nucleoprotein structure. Reguera J, Cusack S, Kolakofsky D. Curr Opin Virol 5 7-15 (2014)
- Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials. Olschläger S, Flatz L. PLoS Pathog. 9 e1003212 (2013)
- Sensing microbial RNA in the cytosol. Vabret N, Blander JM. Front Immunol 4 468 (2013)
- Strategies for viral RNA stability: live long and prosper. Dickson AM, Wilusz J. Trends Genet. 27 286-293 (2011)
- The molecular biology of nairoviruses, an emerging group of tick-borne arboviruses. Lasecka L, Baron MD. Arch. Virol. 159 1249-1265 (2014)
- A versatile building block: the structures and functions of negative-sense single-stranded RNA virus nucleocapsid proteins. Sun Y, Guo Y, Lou Z. Protein Cell 3 893-902 (2012)
- Human hemorrhagic Fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis. Shao J, Liang Y, Ly H. Pathogens 4 283-306 (2015)
- Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses. Koma T, Huang C, Kolokoltsova OA, Brasier AR, Paessler S. J. Mol. Biol. 425 4893-4903 (2013)
- SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets. Subissi L, Imbert I, Ferron F, Collet A, Coutard B, Decroly E, Canard B. Antiviral Res. 101 122-130 (2014)
- Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever. McLay L, Ansari A, Liang Y, Ly H. Antiviral Res. 97 81-92 (2013)
- RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms. Weber M, Weber F. Cytokine Growth Factor Rev. 25 621-628 (2014)
- An evolving arsenal: viral RNA detection by RIG-I-like receptors. Fitzgerald ME, Rawling DC, Vela A, Pyle AM. Curr. Opin. Microbiol. 20 76-81 (2014)
- Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus. Sevajol M, Subissi L, Decroly E, Canard B, Imbert I. Virus Res. 194 90-99 (2014)
- The role of innate immunity in conditioning mosquito susceptibility to West Nile virus. Prasad AN, Brackney DE, Ebel GD. Viruses 5 3142-3170 (2013)
- Molecular pathogenesis of viral hemorrhagic fever. Basler CF. Semin Immunopathol 39 551-561 (2017)
- Segmented negative-strand RNA viruses and RIG-I: divide (your genome) and rule. Weber M, Weber F. Curr. Opin. Microbiol. 20 96-102 (2014)
- Arenavirus Quasispecies and Their Biological Implications. Grande-Pérez A, Martin V, Moreno H, de la Torre JC. Curr Top Microbiol Immunol 392 231-276 (2016)
- Novel paradigms of innate immune sensing of viral infections. Hare D, Mossman KL. Cytokine 63 219-224 (2013)
- Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses. Radoshitzky SR, Kuhn JH, de Kok-Mercado F, Jahrling PB, Bavari S. Expert Opin Drug Discov 7 613-632 (2012)
- Making vaccines "on demand": a potential solution for emerging pathogens and biodefense? De Groot AS, Einck L, Moise L, Chambers M, Ballantyne J, Malone RW, Ardito M, Martin W. Hum Vaccin Immunother 9 1877-1884 (2013)
- Improving the Breadth of the Host's Immune Response to Lassa Virus. Zapata JC, Medina-Moreno S, Guzmán-Cardozo C, Salvato MS. Pathogens 7 (2018)
- New World Arenavirus Biology. Sarute N, Ross SR. Annu Rev Virol 4 141-158 (2017)
- Novel drug discovery approaches for treating arenavirus infections. Pasquato A, Kunz S. Expert Opin Drug Discov 11 383-393 (2016)
- Current drug discovery strategies against arenavirus infections. Pasquato A, Burri DJ, Kunz S. Expert Rev Anti Infect Ther 10 1297-1309 (2012)
- Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures. Lerolle S, Freitas N, Cosset FL, Legros V. Viruses 13 784 (2021)
- Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses. Mantlo E, Paessler S, Huang C. Vaccines (Basel) 7 (2019)
- Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors. Brisse ME, Ly H. Front Immunol 10 372 (2019)
- Lassa fever - the road ahead. Garry RF. Nat Rev Microbiol 21 87-96 (2023)
- Nucleocapsid proteins: roles beyond viral RNA packaging. Ding B, Qin Y, Chen M. Wiley Interdiscip Rev RNA 7 213-226 (2016)
- Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments. Murphy HL, Ly H. Virulence 12 2989-3014 (2021)
- Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Murphy H, Ly H. Vaccines (Basel) 10 1668 (2022)
- Viral evasion of the interferon response at a glance. Zhu J, Chiang C, Gack MU. J Cell Sci 136 jcs260682 (2023)
- Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5. Brisse M, Ly H. Front Immunol 10 1586 (2019)
- Distinct Molecular Mechanisms of Host Immune Response Modulation by Arenavirus NP and Z Proteins. Stott RJ, Strecker T, Foster TL. Viruses 12 (2020)
- Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion. Pleet ML, DeMarino C, Stonier SW, Dye JM, Jacobson S, Aman MJ, Kashanchi F. Viruses 11 (2019)
- Minding the message: tactics controlling RNA decay, modification, and translation in virus-infected cells. Burgess HM, Vink EI, Mohr I. Genes Dev 36 108-132 (2022)
- Negative and ambisense RNA virus ribonucleocapsids: more than protective armor. Sabsay KR, Te Velthuis AJW. Microbiol Mol Biol Rev 87 e0008223 (2023)
- Progress in Anti-Mammarenavirus Drug Development. Kim YJ, Venturini V, de la Torre JC. Viruses 13 1187 (2021)
- Protection of eIF2B from inhibitory phosphorylated eIF2: A viral strategy to maintain mRNA translation during the PKR-triggered integrated stress response. Ito T, Wuerth JD, Weber F. J Biol Chem 299 105287 (2023)
- Replication of the coronavirus genome: A paradox among positive-strand RNA viruses. Grellet E, L'Hôte I, Goulet A, Imbert I. J Biol Chem 298 101923 (2022)
- Structural and molecular biology of Sabiá virus. Bezerra EH, Melo-Hanchuk TD, Marques RE. Exp Biol Med (Maywood) 248 1624-1634 (2023)
- Structural biology of SARS-CoV-2: open the door for novel therapies. Yan W, Zheng Y, Zeng X, He B, Cheng W. Signal Transduct Target Ther 7 26 (2022)
- The Activated Macrophage - A Tough Fortress for Virus Invasion: How Viruses Strike Back. Banete A, Barilo J, Whittaker R, Basta S. Front Microbiol 12 803427 (2021)
- The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity. Ogando NS, Ferron F, Decroly E, Canard B, Posthuma CC, Snijder EJ. Front Microbiol 10 1813 (2019)
- The Innate Antiviral Response in Animals: An Evolutionary Perspective from Flagellates to Humans. Majzoub K, Wrensch F, Baumert TF. Viruses 11 (2019)
- The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid. Šantak M, Matić Z. Viruses 14 521 (2022)
- The Virus-Host Interplay in Junín Mammarenavirus Infection. Gallo GL, López N, Loureiro ME. Viruses 14 1134 (2022)
- The mechanism of genome replication and transcription in bunyaviruses. Malet H, Williams HM, Cusack S, Rosenthal M. PLoS Pathog 19 e1011060 (2023)
- Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway. Rojas JM, Alejo A, Martín V, Sevilla N. Cell Mol Life Sci 78 1423-1444 (2021)